Anti-programmed cell death protein 1 (anti-PD1) immunotherapy induced autoimmune polyendocrine syndrome type II (APS-2): a case report and review of the literature nork Ashray Gunjur, Oliver Klein, Damien Kee, Jonathan Cebon

Testu osoa

Characterising the phenotypic evolution of circulating tumour cells during treatment nork Simon Chang-Hao Tsao, Jing Wang, Yuling Wang, Andreas Behren, Jonathan Cebon, Matt Trau

Testu osoa

Intercellular Resistance to BRAF Inhibition Can Be Mediated by Extracellular Vesicle–Associated PDGFRβ nork Laura J. Vella, Andreas Behren, Bradley Coleman, David W. Greening, Andrew F. Hill, Jonathan Cebon

Testu osoa

A cancer vaccine induces expansion of NY-ESO-1-specific regulatory T cells in patients with advanced melanoma. nork Lisa M Ebert, Sarah E MacRaild, Damien Zanker, Ian D Davis, Jonathan Cebon, Weisan Chen

Testu osoa

PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation nork Candani S. A. Tutuka, Miles C. Andrews, John M. Mariadason, Paul Ioannidis, Christopher Hudson, Jonathan Cebon, Andreas Behren

Testu osoa

Histological diagnosis of immune checkpoint inhibitor induced acute renal injury in patients with metastatic melanoma: a retrospective case series report nork Sebastian Hultin, Kazi Nahar, Alexander M. Menzies, Georgina V. Long, Suran L. Fernando, Victoria Atkinson, Jonathan Cebon, Muh Geot Wong

Testu osoa

Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Bacillus Calmette–Guérin followed by Ipilimumab in Patients with Advanced Metastat... nork Jessica Da Gama Duarte, Jessica Da Gama Duarte, Jessica Da Gama Duarte, Sagun Parakh, Sagun Parakh, Sagun Parakh, Miles C. Andrews, Miles C. Andrews, Miles C. Andrews, Miles C. Andrews, Katherine Woods, Katherine Woods, Katherine Woods, Anupama Pasam, Anupama Pasam, Anupama Pasam, Candani Tutuka, Candani Tutuka, Candani Tutuka, Simone Ostrouska, Simone Ostrouska, Jonathan M. Blackburn, Jonathan M. Blackburn, Andreas Behren, Andreas Behren, Andreas Behren, Jonathan Cebon, Jonathan Cebon, Jonathan Cebon

Testu osoa

PDCD1 Polymorphisms May Predict Response to Anti-PD-1 Blockade in Patients With Metastatic Melanoma nork Sagun Parakh, Sagun Parakh, Sagun Parakh, Ashan Musafer, Ashan Musafer, Sabrina Paessler, Tom Witkowski, Tom Witkowski, Connie S. N. Li Wai Suen, Candani S. A. Tutuka, Matteo S. Carlino, Matteo S. Carlino, Alexander M. Menzies, Alexander M. Menzies, Richard A. Scolyer, Richard A. Scolyer, Richard A. Scolyer, Jonathan Cebon, Jonathan Cebon, Jonathan Cebon, Alexander Dobrovic, Alexander Dobrovic, Georgina V. Long, Georgina V. Long, Georgina V. Long, Oliver Klein, Oliver Klein, Andreas Behren, Andreas Behren, Andreas Behren

Testu osoa

Divergent T-cell receptor recognition modes of a HLA-I restricted extended tumour-associated peptide nork Kok Fei Chan, Benjamin S. Gully, Stephanie Gras, Dennis X. Beringer, Lars Kjer-Nielsen, Jonathan Cebon, James McCluskey, Weisan Chen, Jamie Rossjohn

Testu osoa

Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial nork Linda Mileshkin, Ben Markman, Oliver Klein, Damien Kee, Jonathan Cebon, Andreas Behren, Matteo Carlino, Bo Gao, Jessica da Gama Duarte, Luke Quigley, Louise Jackett, Richelle Linklater, Andrew Strickland, Clare Scott, Jodie Palmer

Testu osoa

A novel BH3-mimetic, AZD0466, targeting BCL-XL and BCL-2 is effective in pre-clinical models of malignant pleural mesothelioma nork Surein Arulananda, Megan O’Brien, Marco Evangelista, Laura J. Jenkins, Ashleigh R. Poh, Marzena Walkiewicz, Trishe Leong, John M. Mariadason, Jonathan Cebon, Srividya B. Balachander, Justin R. Cidado, Erinna F. Lee, Thomas John, Walter D. Fairlie

Testu osoa

A novel HLA-B18 restricted CD8+ T cell epitope is efficiently cross-presented by dendritic cells from soluble tumor antigen. nork Rona Y Zhao, Nicole A Mifsud, Kun Xiao, Kok-Fei Chan, Sara Oveissi, Heather M Jackson, Nektaria Dimopoulos, Philippe Guillaume, Ashley J Knights, Tamara Lowen, Neil C Robson, Sarah E Russell, Emmanuel Scotet, Ian D Davis, Eugene Maraskovsky, Jonathan Cebon, Immanuel F Luescher, Weisan Chen

Testu osoa

Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma nork Surein Arulananda, Megan O’Brien, Marco Evangelista, Tiffany J. Harris, Nikita S. Steinohrt, Laura J. Jenkins, Marzena Walkiewicz, Robert J. J. O’Donoghue, Ashleigh R. Poh, Bibhusal Thapa, David S. Williams, Trishe Leong, John M. Mariadason, Xia Li, Jonathan Cebon, Erinna F. Lee, Thomas John, W. Douglas Fairlie

Testu osoa

Correction: Frequent Mutations in Human Melanoma. nork Otavia L. Caballero, Qi Zhao, Donata Rimoldi, Brian J. Stevenson, Suzanne Svobodová, Sylvie Devalle, Ute F. Röhrig, Anna Pagotto, Olivier Michielin, Daniel Speiser, Jedd D. Wolchok, Cailian Liu, Tanja Pejovic, Kunle Odunsi, Francis Brasseur, Benoit J. Van den Eynde, Lloyd J. Old, Xin Lu, Jonathan Cebon, Robert L. Strausberg, Andrew J. Simpson

Testu osoa

Frequent MAGE mutations in human melanoma. nork Otavia L Caballero, Qi Zhao, Donata Rimoldi, Brian J Stevenson, Suzanne Svobodová, Sylvie Devalle, Ute F Röhrig, Anna Pagotto, Olivier Michielin, Daniel Speiser, Jedd D Wolchok, Cailian Liu, Tanja Pejovic, Kunle Odunsi, Francis Brasseur, Benoit J Van den Eynde, Lloyd J Old, Xin Lu, Jonathan Cebon, Robert L Strausberg, Andrew J Simpson

Testu osoa